Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Regulated information In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”)...
-
Gereglementeerde informatie In overeenstemming met de vereisten van artikel 14 van de Belgische wet van 2 mei 2007 over de openbaarmaking van belangrijke deelnemingen in emittenten, maakt Ontex...
-
NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- SueWallSt alerts investors in Via Transportation, Inc. (NYSE: VIA) that a securities class action has been filed on behalf of shareholders who purchased...
-
New York, NY, July 28, 2026 (GLOBE NEWSWIRE) -- SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that Rakesh Manani joined the...
-
Keynote speakers including Shaquille O’Neal, basketball legend and investment icon, and George Lee, Co-Head of the Goldman Sachs Global Institute, headline event shaping emerging AI themes for...
-
SINGAPORE and SHANGHAI, July 28, 2026 (GLOBE NEWSWIRE) -- H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” or the “Company”), a key player in the global hotel industry, today announced...
-
Scribe Therapeutics announces closing of initial public offering
-
DALLAS, July 27, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) ("Applied Digital" or the Company"), a U.S.-based designer, developer, owner, and operator of large-scale,...
-
Transaction in Own Shares 24 July, 2026 • • • • • • • • • • • • • • • • Shell plc (the 'Company') announces that on 24 July, 2026 it purchased the following number of Shares for cancellation. ...
-
Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology that can fuel long-term growthFB102 Phase 1b studies in...